SESEN BIO INC (SESN) Stock News

12 Health Care Stocks Moving In Monday's Pre-Market Session

Mentions: ESPR ADAP VTVT ACRS ...

Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket

Gainers Secoo Holding Limited (NASDAQ: SECO) rose 44% to $1.44 in pre-market trading after dipping over 31% on Friday.

Mentions: TRKA ALZN IONM CRIS ...

Sesen Bio stockholders approve 1-for-20 reverse stock split (NASDAQ:SESN)

Sesen Bio (SESN) stockholders on Thursday approved effecting a 1-for-20 reverse stock split of the company's issued and outstanding shares. Read more here.

Sesen Bio wins shareholder approval for Carisma merger (NASDAQ:SESN)

Sesen Bio (SESN) announced Thursday that its shareholders greenlighted the company’s pending merger with Carisma Therapeutics at a special stockholder meeting. Read the full story here.

Sesen Bio Stockholders Approve Merger with Carisma Therapeutics

Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results

Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote “FOR” All Proposals to Approve Pending Merger With Carisma

Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meeting

Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Merger

BML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics

SESN stock gains on amended terms for merger with Carisma (NASDAQ:SESN)

Sesen Bio (SESN) added ~11% pre-market Tuesday after an agreement with two key shareholders to obtain support for its pending merger with Carisma Therapeutics. Read the full story here.

Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger

Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger

Sesen Bio receives Nasdaq delisting notice (NASDAQ:SESN)

Sesen Bio (SESN) has received a Nasdaq delisting notice as its share price has fallen below $1.

Sesen Bio Receives NASDAQ Delisting Notice

Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders

Investor Group Issues Letter to the Boards of Sesen Bio and Carisma Rejecting Their Apparent Attempt to Purchase Merger Support

Sesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connection with Pending Merger with Carisma Therapeutics

Investor Group Issues Letter to Sesen Bio’s Board of Directors Regarding Intent to Vote AGAINST Proposed Carisma Merger

Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics

Sesen Bio investors plan to vote against Carisma merger(NASDAQ:SESN)

Sesen Bio (SESN) investors reiterated their plan to vote against the merger with Carisma Therapuetics, calling it a an "illogical, value-destructive" deal. Sesen rose 4.2%.Bradley L

Investor Group Reiterates Intent to Vote AGAINST Sesen Bio’s Value-Destructive Merger with Carisma